AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
VENLAFAXINE HYDROCHLORIDE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LAFEKS 150 CAPSULE | 2024/13.2.1/6646 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| LAFEKS 37.5 CAPSULE | 2024/13.2.1/6644 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| LAFEKS 75 CAPSULE | 2024/13.2.1/6645 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| EFTRO 150 CAPSULE; ORAL | 2025/13.2.1/7135 | HETERO LABS LTD | active | 31 Dec 2027 |
| EFTRO 75 CAPSULE; ORAL | 2025/13.2.1/7134 | HETERO LABS LTD | active | 31 Dec 2027 |
VENLAFAXINE HYDROCHLORIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing VENLAFAXINE HYDROCHLORIDE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track VENLAFAXINE HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.